ArticleInternational journal of hematology2021

Risk factors for delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia and lymphoma.

Takaaki Nakano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.